These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16986047)

  • 1. The role of the urologist in treating patients with hormone-refractory prostate cancer.
    Crawford ED
    Rev Urol; 2003; 5 Suppl 2(Suppl 2):S48-52. PubMed ID: 16986047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy for hormone-refractory prostate cancer.
    Shelley M; Harrison C; Coles B; Staffurth J; Wilt TJ; Mason MD
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005247. PubMed ID: 17054249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urologists' attitudes regarding information sharing with prostate cancer patients--is there a common ground for collaboration with family physicians?
    Cohen Castel O; Alperin M; Ungar L; Kravtsov I; Amiel GE; Karkabi K
    J Cancer Educ; 2011 Jun; 26(2):315-21. PubMed ID: 20972846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge, attitudes and beliefs towards management of men with locally advanced prostate cancer following radical prostatectomy: an Australian survey of urologists.
    Brown B; Young J; Kneebone AB; Brooks AJ; Dominello A; Haines M
    BJU Int; 2016 Apr; 117 Suppl 4():35-44. PubMed ID: 25585989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing attitudes towards management of men with locally advanced prostate cancer following radical prostatectomy: A follow-up survey of Australia-based urologists.
    Brown B; Egger S; Young J; Kneebone AB; Brooks AJ; Dominello A; Haines M
    J Med Imaging Radiat Oncol; 2016 Dec; 60(6):744-755. PubMed ID: 27346844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comparison of Radiologists' and Urologists' Opinions Regarding Prostate MRI Reporting: Results From a Survey of Specialty Societies.
    Spilseth B; Ghai S; Patel NU; Taneja SS; Margolis DJ; Rosenkrantz AB
    AJR Am J Roentgenol; 2018 Jan; 210(1):101-107. PubMed ID: 29064758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urologist practice patterns in the management of premature ejaculation: a nationwide survey.
    Shindel A; Nelson C; Brandes S
    J Sex Med; 2008 Jan; 5(1):199-205. PubMed ID: 17971107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urologists' personal feelings on PSA screening and prostate cancer treatment.
    Wenzler DL; Rosenberg BH
    J Eval Clin Pract; 2014 Aug; 20(4):408-10. PubMed ID: 24798149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urologists' attitudes regarding cancer clinical research.
    Swanson GP; Carpenter WR; Thompson IM; Crawford ED
    Urology; 2007 Jul; 70(1):19-24. PubMed ID: 17656200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of American urologists' approach to hormonal management of prostate cancer.
    Warren KS; Osborn J; Chodak GW
    Urology; 2006 Dec; 68(6):1305-7. PubMed ID: 17169651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends and attitudes in surgical management of benign prostatic hyperplasia.
    Lee NG; Xue H; Lerner LB
    Can J Urol; 2012 Apr; 19(2):6170-5. PubMed ID: 22512959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Opinion Regarding Multidisciplinary Cancer Clinic Utilization for the Management of Prostate Cancer.
    Lama DJ; Kasson M; Hoge C; Guan T; Rao M; Struve T; Verma S; Sidana A
    J Clin Imaging Sci; 2021; 11():29. PubMed ID: 34221638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance-targeted biopsy.
    Muthigi A; Sidana A; George AK; Kongnyuy M; Maruf M; Valayil S; Wood BJ; Pinto PA
    Urol Oncol; 2017 Jan; 35(1):32.e1-32.e7. PubMed ID: 27743850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. United States radiation oncologists' and urologists' opinions about screening and treatment of prostate cancer vary by region.
    McNaughton Collins M; Barry MJ; Zietman A; Albertsen PC; Talcott JA; Walker Corkery E; Elliott DB; Fowler FJ
    Urology; 2002 Oct; 60(4):628-33. PubMed ID: 12385923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What the prostate cancer patient should know: variations in urologists' opinions.
    Feldman-Stewart D; Brundage MD; Hayter C; Davidson JR; Groome P; Nickel JC
    Can J Urol; 1997 Dec; 4(4):438-444. PubMed ID: 12735808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Achieving treatment goals for hormone-refractory prostate cancer with chemotherapy.
    Berry W; Eisenberger M
    Oncologist; 2005; 10 Suppl 3():30-9. PubMed ID: 16368869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acupuncture in urological practice--a survey of urologists in England.
    Tempest H; Reynard J; Bryant RJ; Hamdy FC; Larré S
    Complement Ther Med; 2011 Feb; 19(1):27-31. PubMed ID: 21296264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urologists' Current Practices in Screening and Treating Men With a Family History of Prostate Cancer.
    Rudichuk L; Vogel KJ; Wang CH; Helfand BT; Selkirk CG
    Urology; 2017 Jan; 99():180-185. PubMed ID: 27645528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of reimbursement policy and urologists' characteristics with the use of medical androgen deprivation therapy for clinically localized prostate cancer.
    Quek RG; Master VA; Portier KM; Ward KC; Lin CC; Virgo KS; Lipscomb J
    Urol Oncol; 2014 Aug; 32(6):748-60. PubMed ID: 24840868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urologists' attitudes to sexual complications of LUTS/BPH treatments.
    Giona S; Ganguly I; Muir G
    World J Urol; 2018 Sep; 36(9):1449-1453. PubMed ID: 29680951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.